Practical thresholds
A claim becomes stronger when it survives comparison, scale, safety review and routine use beyond the first demonstration.
Signatera
This page places Signatera inside the scientific, clinical and commercial systems that define its importance.
We use Signatera as an entry point into the wider machinery of modern biotech.
Readers can expect careful attention to clinical validity, screening utility, laboratory workflows, false positives and payer expectations, with emphasis on what is known, what is still uncertain and what would make the next milestone meaningful.
As the field moves, this page will help separate durable advances from temporary attention, with the wider context collected under Diagnostics.
Questions that matter
Why it matters now
The first test is whether Signatera changes what researchers, clinicians, builders or patients can decide with more confidence.
Evidence to watch
Important signals include independent replication, transparent endpoints, method details and use by groups outside the original sponsor.